{"DataElement":{"publicId":"6734211","version":"1","preferredName":"Allogeneic Hematopoietic Stem Cell Transplantation Administration Timepoint Type","preferredDefinition":"The response that indicates the time point when the patient received the allogeneic stem cell transplant.","longName":"ALL_SCT_TIMEPT_TYP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2670040","version":"1","preferredName":"Allogeneic Hematopoietic Stem Cell Transplantation Administration","preferredDefinition":"information related to the administration of a clinical treatment in which Hematopoietic Stem Cell capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another.","longName":"HSCT_ADM","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2641701","version":"1","preferredName":"Allogeneic Hematopoietic Stem Cell Transplantation","preferredDefinition":"A clinical treatment in which HSC capable of reconstituting the immune system and blood production (hematopoiesis) are transferred from one genetically dissimilar individual to another. The donor and recipient may or may not be related. 2005","longName":"C46089","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allogeneic Hematopoietic Stem Cell Transplantation","conceptCode":"C46089","definition":"A clinical treatment in which hematopoietic stem cells (HSCs) are transferred from one genetically dissimilar individual to another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3113EEA9-8075-4DFA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-22","modifiedBy":"ONEDATA","dateModified":"2007-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320521","version":"1","preferredName":"Administration","preferredDefinition":"The act of administration.","longName":"C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-053F-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36A2FDC1-8F1C-5E69-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-08-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6734130","version":"1","preferredName":"Stem Cell Transplant Timepoint Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6734130v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"PR1","valueDescription":"Clinical Trial Epoch 1 Partial Remission","ValueMeaning":{"publicId":"6734132","version":"1","preferredName":"Clinical Trial Epoch 1 Partial Remission","longName":"6734132","preferredDefinition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.: A number with no fractional part, including the negative and positive numbers as well as zero.::1: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Epoch","conceptCode":"C71738","definition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8773F62A-AE0C-5206-E053-F662850A9179","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8773F62A-AE25-5206-E053-F662850A9179","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","deletedIndicator":"No"},{"value":"CR2","valueDescription":"Clinical Trial Epoch 2 Complete Remission","ValueMeaning":{"publicId":"6734133","version":"1","preferredName":"Clinical Trial Epoch 2 Complete Remission","longName":"6734133","preferredDefinition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.: A number with no fractional part, including the negative and positive numbers as well as zero.::2: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Epoch","conceptCode":"C71738","definition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8773F62A-AE33-5206-E053-F662850A9179","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8773F62A-AE4C-5206-E053-F662850A9179","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","deletedIndicator":"No"},{"value":"PR2","valueDescription":"Clinical Trial Epoch 2 Partial Remission","ValueMeaning":{"publicId":"6734131","version":"1","preferredName":"Clinical Trial Epoch 2 Partial Remission","longName":"6734131","preferredDefinition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.: A number with no fractional part, including the negative and positive numbers as well as zero.::2: A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Epoch","conceptCode":"C71738","definition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Partial Remission","conceptCode":"C18058","definition":"A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8773F62A-ADE5-5206-E053-F662850A9179","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8773F62A-ADFE-5206-E053-F662850A9179","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","deletedIndicator":"No"},{"value":"CR1","valueDescription":"Clinical Trial Epoch 1 Complete Remission","ValueMeaning":{"publicId":"6734134","version":"1","preferredName":"Clinical Trial Epoch 1 Complete Remission","longName":"6734134","preferredDefinition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.: A number with no fractional part, including the negative and positive numbers as well as zero.::1: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial Epoch","conceptCode":"C71738","definition":"A portion of a study containing one or more study segments with a consistent objective such as screening subjects or treating disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8773F62A-AE5A-5206-E053-F662850A9179","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8773F62A-AE73-5206-E053-F662850A9179","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8773F62A-ADCA-5206-E053-F662850A9179","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6705585","version":"1","longName":"PTCL","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"When did the patient undergo","type":"Preferred Question Text","description":"When did the patient undergo allogeneic stem cell transplant?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"877636E9-8B55-59FB-E053-F662850A7C11","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}